These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 10446459)
1. Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant MCF-7 breast cancer cells. Parissenti AM; Gannon BR; Villeneuve DJ; Kirwan-rhude AF; Chadderton A; Glück S Int J Cancer; 1999 Sep; 82(6):893-900. PubMed ID: 10446459 [TBL] [Abstract][Full Text] [Related]
2. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866 [TBL] [Abstract][Full Text] [Related]
3. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells. Budworth J; Gant TW; Gescher A Br J Cancer; 1997; 75(9):1330-5. PubMed ID: 9155054 [TBL] [Abstract][Full Text] [Related]
4. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933 [TBL] [Abstract][Full Text] [Related]
5. Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation. Kim HG; Hien TT; Han EH; Hwang YP; Choi JH; Kang KW; Kwon KI; Kim BH; Kim SK; Song GY; Jeong TC; Jeong HG Br J Pharmacol; 2011 Mar; 162(5):1096-108. PubMed ID: 21054339 [TBL] [Abstract][Full Text] [Related]
6. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine. David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303 [TBL] [Abstract][Full Text] [Related]
7. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells. Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of multidrug resistance in breast cancer. Glazer RI; Rohlff C Breast Cancer Res Treat; 1994; 31(2-3):263-71. PubMed ID: 7881104 [TBL] [Abstract][Full Text] [Related]
9. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
10. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells]. Huang C; Cao P; Xie Z; Zhu H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):317-22. PubMed ID: 21566283 [TBL] [Abstract][Full Text] [Related]
11. [Synergic effect of Na(+)-K(+) ATPaseB1 and adriamycin on inhibition of cell proliferation and reversal of drug resistance in breast cancer MCF-7 cells]. Qi YY; Liu K; Zhang J; Li K; Ren JJ; Lin P Ai Zheng; 2009 Aug; 28(8):861-7. PubMed ID: 19664334 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791 [TBL] [Abstract][Full Text] [Related]
13. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C; Guan X; Xue H; Wang P; Wang M; Gai X Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760 [TBL] [Abstract][Full Text] [Related]
14. Regulation of P-glycoprotein 1 and 2 gene expression and protein activity in two MCF-7/Dox cell line subclones. Davies R; Budworth J; Riley J; Snowden R; Gescher A; Gant TW Br J Cancer; 1996 Feb; 73(3):307-15. PubMed ID: 8562335 [TBL] [Abstract][Full Text] [Related]
15. Combination of 7- Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024 [TBL] [Abstract][Full Text] [Related]
16. Determining MDR1/P-glycoprotein expression in breast cancer. Faneyte IF; Kristel PM; van de Vijver MJ Int J Cancer; 2001 Jul; 93(1):114-22. PubMed ID: 11391630 [TBL] [Abstract][Full Text] [Related]
17. Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants. Cvijic ME; Chin KV Cell Growth Differ; 1997 Dec; 8(12):1243-7. PubMed ID: 9419412 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells. Hien TT; Kim HG; Han EH; Kang KW; Jeong HG Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. Scala S; Budillon A; Zhan Z; Cho-Chung YS; Jefferson J; Tsokos M; Bates SE J Clin Invest; 1995 Aug; 96(2):1026-34. PubMed ID: 7543490 [TBL] [Abstract][Full Text] [Related]
20. Reversal of adriamycin resistance in human mammary cancer cells by small interfering RNA of MDR1 and MDR3 genes. Xiao L; Gao R; Lu S; Ren L; Wang Z J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):735-7. PubMed ID: 17357504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]